What's new

Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 11, Status: Authorised

Apr 28, 2025 - 16:54
 0
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

Alex Marquez Takes First MotoGP Win After His Brother Marc Crashes

Next Article

Scrapping Britain’s nuclear power plans would lead to lower energy bills | Letters

Related Posts

Business process description for paediatric medicines d...

Apr 22, 2025  0

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 28, 2025  0

Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0